EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Aerosolization of viable Mycobacterium tuberculosis bacilli by tuberculosis clinic attendees independent of sputum-Xpert Ultra status

Benjamin Patterson iD, Ryan Dinkele iD, Sophia Gessner, Anastasia Koch iD, Zeenat Hoosen iD, Vanessa January, Bryan Leonard, Andrea McKerry, Ronnett Seldon, Andiswa Vazi, Sabine Hermans iD, Frank Cobelens iD und 2 weitere

Proceedings of the National Academy of Sciences · 19.03.2024 · 121 (12)

DOI: 10.1073/pnas.2314813121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 12.03.2024. Verfasst von Benjamin Patterson und 13 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam Institute for Global Health and Development, University of Amsterdam, Amsterdam 1105, The Netherlands. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Bacillus, Tuberculosis, Pulmonary, Tuberculosis. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, South African Medical Research Council, HHS | National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Potential Mycobacterium tuberculosis ( Mtb ) transmission during different pulmonary tuberculosis (TB) disease states is poorly understood. We quantified viable aerosolized Mtb from TB clinic attendees following diagnosis and through six months’ follow-up thereafter. Presumptive TB patients (n=102) were classified by laboratory, radiological, and clinical features into Group A: Sputum-Xpert Ultra-positive TB (n=52), Group B: Sputum-Xpert Ultra-negative TB (n=20), or Group C: TB undiagnosed (n=30). All groups were assessed for Mtb bioaerosol release at baseline, and subsequently at 2 wk, 2 mo, and 6 mo. Groups A and B were notified to the national TB program and received standard anti-TB chemotherapy; Mtb was isolated from 92% and 90% at presentation, 87% and 74% at 2 wk, 54% and 44% at 2 mo and 32% and 20% at 6 mo, respectively. Surprisingly, similar numbers were detected in Group C not initiating TB treatment: 93%, 70%, 48% and 22% at the same timepoints. A temporal association was observed between Mtb bioaerosol release and TB symptoms in all three groups. Persistence of Mtb bioaerosol positivity was observed in ~30% of participants irrespective of TB chemotherapy. Captured Mtb bacilli were predominantly acid-fast stain-negative and poorly culturable; however, three bioaerosol samples yielded sufficient biomass following culture for whole-genome sequencing, revealing two different Mtb lineages. Detection of viable aerosolized Mtb in clinic attendees, independent of TB diagnosis, suggests that unidentified Mtb transmitters might contribute a significant attributable proportion of community exposure. Additional longitudinal studies with sputum culture-positive and -negative control participants are required to investigate this possibility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisBacillusTuberculosis, PulmonaryTuberculosisHumansSputumBacillotaSensitivity and Specificity

Stichwörter der Autor:innen

aerosol samplingsubclinicaltuberculosis

Autor:innen und Institutionen

  • Amsterdam Institute for Global Health and Development, University of Amsterdam, Amsterdam 1105, The Netherlands.
  • South African Medical Research Council, National Health Laboratory Service, University of Cape Town Molecular Mycobacteriology Research Unit & Department of Science and Technology/National Research Foundation Centre of…
  • Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa.
  • Aerobiology and TB Research Unit, Desmond Tutu Health Foundation, Cape Town 7975, South Africa.
  • Wellcome Centre for Infectious Diseases Research in Africa, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa.

ORCID-Profile: Benjamin Patterson, Ryan Dinkele, Anastasia Koch, Zeenat Hoosen, Sabine Hermans, Frank Cobelens, Digby F Warner, Robin Wood

Förderung

  • NIAID NIH HHS
  • South African Medical Research Council
  • HHS | National Institutes of Health
  • Myco3V Tuberculosis Research Unit
  • Research Council of Norway

Zitieren

APA

Patterson, B., Dinkele, R., Gessner, S., Koch, A., Hoosen, Z., January, V., Leonard, B., McKerry, A., Seldon, R., Vazi, A., Hermans, S., Cobelens, F., Warner, D. F., & Wood, R. (2024). Aerosolization of viable Mycobacterium tuberculosis bacilli by tuberculosis clinic attendees independent of sputum-Xpert Ultra status. Proceedings of the National Academy of Sciences, 121(12). https://doi.org/10.1073/pnas.2314813121

Vancouver

Patterson B, Dinkele R, Gessner S, Koch A, Hoosen Z, January V, et al. Aerosolization of viable Mycobacterium tuberculosis bacilli by tuberculosis clinic attendees independent of sputum-Xpert Ultra status. Proceedings of the National Academy of Sciences. 2024;121(12). doi:10.1073/pnas.2314813121

BibTeX
@article{Patterson2024,
  author = {Patterson, Benjamin and Dinkele, Ryan and Gessner, Sophia and Koch, Anastasia and Hoosen, Zeenat and January, Vanessa and Leonard, Bryan and McKerry, Andrea and Seldon, Ronnett and Vazi, Andiswa and Hermans, Sabine and Cobelens, Frank and Warner, Digby F and Wood, Robin},
  title = {Aerosolization of viable Mycobacterium tuberculosis bacilli by tuberculosis clinic attendees independent of sputum-Xpert Ultra status},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {12},
  doi = {10.1073/pnas.2314813121}
}
Kostenlos starten →